Pfizer, one of the primary players in the Covid-19 vaccine manufacturing race, with over 2.5 billion doses administered, now has an antiviral pill to treat the infection.
The preliminary data of Pfizer's experimental antiviral pill to treat Covid-19 shows an 89 per cent decrease in the chance of hospitalisation or death for adults at risk of severe disease. Watch the video here to get the details.
Be the first to comment